• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 9 Aug

    SKYX Reports Second Quarter 2023 Financial Results with $15 Million in Sales Reflecting a Partial Quarter Including Sales of its Safe Plug & Play Products

    Company Sequentially Reduces Net Cash Used in Operating Activities to $2.5 Million MIAMI, FL / ACCESSWIRE / August 9, 2023 / (NASDAQ:SKYX) (d/b/a "Sky Technologies"), a highly disruptive platform technology company with over 60 pending and issued patents globally with a mission to make homes and buildings become safe and… Read More..

    Share this:
  • 9 Aug

    Quoin Pharmaceuticals’ Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholders

    NEW YORK, NY - (NewMediaWire) - August 09, 2023 - PCG Digital --Quoin Pharmaceuticals (Nasdaq:QNRX), a clinical stage pharmaceutical company specializing in rare and orphan diseases, has achieved significant milestones in its mission to deliver the first approved treatment for Netherton Syndrome, a rare hereditary genetic disease. The Company recently… Read More..

    Share this:
  • 9 Aug

    Oncocyte Regains Compliance With Nasdaq Listing Requirements

    IRVINE, CA / ACCESSWIRE / August 9, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it has received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market ("Nasdaq") stating that the Company has regained compliance with the Nasdaq minimum bid price continued listing… Read More..

    Share this:
« Previous 1 … 153 154 155 156 157 … 253 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact